85-1342-41 Chymostatin (Actinomycetes) 5mg C5068-40
特徴
- Protease inhibitor produced by Actinomycetes. Inhibits serine and cysteine proteases: a, b, g, d chymotrypsin, papain, cathepsin A, B and C. Mixture of Types A, B and C where A=Leu, B= Val, C= Ile. Mostly Type A.
- Synonyms:(S)-1-Carboxy-2-phenylethyl)-carbamoyl-α-[2-iminohexahydro-4(S)-pyrimidyl]-(S)-glycyl-X-phenylalaninal
- Molecular Formula:C31H41N7O6
- Molecular Weight:604.9
- Appearance:White to off-white powder
- Solubility (10mg/ml, glacial acetic acid):Colorless to yellow, clear, complete
- Percentage of X Components:Leu: ~75%Val: ~20%Ile:~5%
- Activity (IC50) (alpha-chymotrypsin/casein, pH 7.4, 37°C):~0.2ug/ml
- Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile glacial acetic acid. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
- Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
- Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
仕様
- Size:5mg
- Source Antigen:Actinomycetes
- Grade:Molecular Biology Grade
- Form:White to off-white powder
- Molecular Formula:C31H41N7O6
- Molecular Weight Non Ab:604.9
- EU Commodity Code:38220090
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-1342-41
Chymostatin (Actinomycetes) 5mg
|
|
|
85-1342-43
Chymostatin (Actinomycetes) 100mg
|
|
|
85-1342-42
Chymostatin (Actinomycetes) 25mg
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





